Banque Cantonale Vaudoise Cassava Sciences Inc Transaction History

Banque Cantonale Vaudoise

  • $2.43 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 17, 2022
BUY
$16.33 - $51.06 $32,659 - $102,120
2,000 New
2,000 $84,000
Q3 2021

Oct 29, 2021
SELL
$41.79 - $135.3 $417,900 - $1.35 Million
-10,000 Closed
0 $0
Q2 2021

Aug 11, 2021
BUY
$32.15 - $89.72 $321,500 - $897,200
10,000 New
10,000 $854,000

Others Institutions Holding SAVA

# of Institutions
191
Shares Held
13.7M
Call Options Held
2.97M
Put Options Held
6.55M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $95.4M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email